Senator Mark Warner (D-Virginia) penned a letter to Google leadership expressing concerns about Med-PaLM 2 — the company’s generative AI tool for healthcare providers that is currently being used by Mayo Clinic and other health systems. The letter requested that Google provide more clarity about its chatbot’s training, accuracy, ethical considerations and deployment in healthcare settings.

Google Cloud and Mayo Clinic recently announced a partnership focused on generative AI — the health system will be deploying a new HIPAA-compliant Google Cloud service called Gen App Builder. The tool enables providers to create a search system for their data, equipped with conversational features powered by Google’s large language models.

Lucem Health recently closed a $7.7 million Series A funding round. The startup’s platform takes in the data required to fuel AI algorithms that give clinicians insights to improve patient care.

Many of the efforts to address healthcare’s burnout crisis have centered on money, such as hiring and retention bonuses, but that isn’t sustainable. Providers don’t have the means to keep throwing money at the problem forever, so they should focus more on creating a workplace culture where employees feel valued and supported.

Machine learning algorithms have reached a familiar milestone in the healthcare industry –in order for them to be more widely embraced by providers, different approaches to roadtesting and validating them are underway.

Mayo Clinic teamed up with digital health platform Memora Health to pilot a new initiative for postpartum patients. They are launching a texting-based program to better engage postpartum patients and have entered a research collaboration to measure the model’s efficacy.

Mayo Clinic recently welcomed seven more healthcare startups to its accelerator program. In exchange for an equity position in each startup, Mayo Clinic gives young digital health companies the opportunity to refine their AI models using its deidentified data sets and subject matter experts.

Digital health startup Lisa Health recently launched Midday, an app it co-developed with Mayo Clinic to help women navigate menopause. The Oakland-based company also announced the close of its $2.5 million oversubscribed seed round led by Radical Ventures.

Medically Home partners with health systems to provide care in patients’ homes. As long as there is a roof, electricity, running water and a bathroom, the company can offer its services.

Michael Howell, chief clinical officer of Google, discussed the ways AI and ML are serving healthcare, as well as some lessons he learned since he started working at Google.

Mayo experts work with the companies to understand AI model requirements, check for fairness and bias in their AI models, help them understand the Food and Drug Administration clearance process and more.

Through the alliance, the two organizations are sharing their extensive clinical data with one another, which will help identify diseases and treatment plans earlier.

Decentralized and hybrid clinical trials have a faster enrollment rate and a higher retention rate than centralized models, research shows.

Novartis is partnering with algorithms startup Anumana to develop a new artificial intelligence-based solution for cardiovascular diseases. The goal is to find ways to detect heart conditions years before symptoms develop in order to enable earlier intervention.

Hospital-at-home advocates often highlight how the care modality improves the patient experience and allows hospitals to better manage capacity. There are other key benefits — such as protecting patients from hospital-acquired infections and improving caregiver’s job satisfaction — that should be brought into the conversation as well, hospital executives say.

Early detection and treatment of heart failure can greatly improve an otherwise poor prognosis. Research from Mayo Clinic suggests artificial intelligence could be used to detect the condition even when no symptoms are present.

PathAI is partnering with Cleveland Clinic to digitize pathology slides and develop and improve PathAI’s machine-learning algorithms that can drive research as well as improve patient outcomes in a clinical setting. Pramana is launching its digital pathology as a service product and has struck a multi-year commercial agreement with Mayo Clinic to digitize 5 million pathology slides.

They led an investment in TripleBlind, a Kansas City-based startup looking to support collaboration between healthcare companies without the need to share raw data.

Eleven health systems have joined the coalition, which aims to extend and expand the existing federal hospital-at-home waivers and create an advanced acute care-at-home delivery model at the Center for Medicare & Medicaid Innovation.

Judges proclaimed winners across three tracks of the digital health startup pitch contest including: Home health, chronic disease management and value-based care, and technology to support payer and provider efficiency.

The algorithm maps interactions between different areas of the brain, which can help guide the placement of electrodes for stimulating devices to treat brain diseases, like epilepsy, and movement disorders.

They plan to commercialize the decision support software, which would surface relevant patient records and recommendations from Mayo Clinic specialists. To start, they will focus on cardiometabolic conditions.

Google is piloting its healthcare data engine, a tool intended to build longitudinal patient records and pull in data from multiple sources. Early work with Mayo Clinic served as a foundation for the technology. 

A new analysis from the Lown Institute identified the most and least racially inclusive hospitals in America, but hospitals at the bottom of the list dispute the methodology. Still, the analysis indicates a troubling trend of racial segregation in healthcare.

The health systems are sinking a combined $100 million into Medically Home Group, which enables clinicians to provide hospital-level care in patients’ homes. The funds are intended to scale the company’s operations and expand access to its care delivery model.

Mayo Clinic is ramping up activity in the remote patient monitoring arena. Its latest move is a collaboration with biomedical technology company NXgenPort, which will focus on an implantable catheter that can remotely monitor cancer patients for complications as they undergo treatment.

Mayo Clinic shared results of a study showing that an AI tool developed by the system could be used to improve diagnosis of low ejection fraction, a type of heart disease. It’s part of a broader push by Mayo Clinic to commercialize AI-based diagnostic tools, starting with spinout company Anumana.

Mayo Clinic struck joint ventures with two startups to develop and commercialize AI diagnostic tools. It’s part of a broader plan by Mayo Clinic to develop more AI tools to support clinical decisions. 

The health system and tech giant are more than a year into their 10-year collaboration. As their partnership evolves, the organizations are looking to create an “AI factory” — an assembly line of AI solutions that are developed at scale and incorporated into clinical workflows.

A group of organizations have come together to work on a solution that will provide digital access to Covid-19 vaccination records. As the country eyes a challenging transition to the new normal, a verifiable vaccine record will be necessary to ensure individual and community safety.